HepNet Study-House

Short description

The German Liver Foundation’s HepNet Study-House is a platform for planning, coordinating, and conducting clinical trials on liver diseases, particularly hepatitis.

Detailed description

The HepNet Study-House supports researchers in planning and conducting clinical trials on liver diseases. It connects study centers and provides infrastructure and scientific expertise for collaborative clinical research projects.

The German Liver Foundation is a cooperation partner of the DZIF. As part of this collaboration, the DZIF can utilize the HepNet Study-House’s infrastructure for clinical research projects, such as conducting studies and establishing patient cohorts.

29 Jan 2024

public

24th Meeting of the Hepatitis Delta International Network (HDIN)

New Hepatitis D treatment options still needed urgently

The largest trial on the treatment of aggressive hepatitis D (delta) worldwide was conducted at the German Liver Foundation’s HepNet Study House. It shows that an extension of treatment duration has

Hannover - Braunschweig

Infectious diseases professorship with a focus on hepatology

Professor Markus Cornberg is Clinical Director of the Helmholtz Centre for Infection Research (HZI) and Co-Director of the Centre for Individualised Infection Medicine (CiiM). He and his translational research group provide the necessary link between hospitals, the HZI, the HepNet Study-House trial ...

German Liver Foundation/HepNet Study-House, Hannover

Liver diseases and their treatment are the focus of the German Liver Foundation (German only). The HepNet Study House…

Hannover - Braunschweig

The HepNet Study-House connects individual study centers in the field of hepatitis research and creates a central platform to conduct clinical studies (Investigator Initiated Trials) and build patient cohorts in the field of viral hepatitis. On the one hand, the Study-House is a contact point for ...